Intermediates for regulated development
Pharma customers need more than a commercial quote. They need clarity on route history, impurity limits, analytical method status, residual solvent controls, packaging, and future change notification. Iff supports early development, validation planning, and commercial sourcing discussions with technical language that QA can review. Recommended product families include chiral intermediates, protected amines, fine chemical starting materials, and custom synthesis programs where confidentiality and documentation quality are both central.